Company profilePharmaceutical#282 of 1,318 in Pakistan✓ No DRAP alerts

LINEAR PHARMA

Pharmaceutical company · 64 brands · 61 molecules

Ranked #73 of 100 companies in Gastro

64 registered products 23 pharmaceutical brands 61 distinct molecules 0 DRAP alerts

Company overview

64
registered products
23
pharmaceutical brands
61
distinct molecules
2
therapeutic classes
0
DRAP alerts

LINEAR PHARMA is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 64 product registrations across 61 distinct molecules. Its portfolio is concentrated in Gastro and Calcium, Combinations With Vitamin D And Other Drugs. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by LINEAR

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Anti-Infectives 1

Top molecules by brand count

Artemether4 brands
Fusidic Acid3 brands
Omeprazole3 brands
Lumefantrine3 brands
Azithromycin2 brands
Ossein Mineral Complex2 brands
Esomeprazole2 brands
Duloxetine1 brand

Therapeutic classes

Gastro · 1Calcium, Combinations With Vitamin D And Other Drugs · 1

Conditions treated

Intestinal & Bowel Syndrome · 1

Price band (DRAP official ceilings)

Registered products priced by source
Servaid1 products · Rs 207 – Rs 207
Median across source: Rs 207

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

SHROOQ PHARMACEUTICALS36 shared molecules
BIO LABS (PVT) LTD.32 shared molecules
NEUTRO PHARMA (PVT) LTD.30 shared molecules
CARAWAY PHARMACEUTICALS27 shared molecules
Albro Pharmaceuticals27 shared molecules
VALOR PHARMACEUTICALS26 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SHROOQ PHARMACEUTICALS holds 21 molecules not in this portfolio
AcitretinAcyclovirAcyclovir Inf/OralCiprofloxacinDiclofenacDiclofenac Potassium
BIO LABS (PVT) LTD. holds 138 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
NEUTRO PHARMA (PVT) LTD. holds 124 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole

Get the full profile for LINEAR

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.